A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression.

Jialin MaZheng YanJiuyang ZhangWenping ZhouZhihua YaoHaiying WangJunfeng ChuShuna YaoShuang ZhaoPeipei ZhangYuanlin XuQingxin XiaJie MaBing WeiShujun YangKangdong LiuYongjun GuoYan-Yan Liu

Published in: Biomarker research (2020)

The genetic predictive model provides a robust tool to identify early progression and determine precision treatment. These findings warrant the development of optimal alternative treatment in clinical trials.

Keyphrases

diffuse large b cell lymphoma
clinical trial
randomized controlled trial
epstein barr virus
genome wide
gene expression
combination therapy
open label
phase ii